NI-071

· Nichi-Iko Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NI-071, covering 2013-06-19 to 2023-01-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE) [Phase 3]